Dendreon's PIPE Round

Dendreon raised a round of funding on June 19, 2003.

Dendreon is a biopharmaceutical company targeting cancer through the discovery, development, commercialization, and manufacturing of novel therapeutics. Its product Provenge is an autologous cellular …

Articles about Dendreon's PIPE Round: